Gliknik Inc.
A company developing therapies for cancer and immune disorders
4
Funding Rounds
$34.9m
Money raised
Overview
A company developing therapies for cancer and immune disorders
- Website:
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Gliknik Inc. has raised a total of $19.9m in funding over 4 rounds.
Key Insights:
- Gliknik Series C round, June 2021: $11.5m
- Gliknik Series B round: $4.9m
- Gliknik funding round, January 2011: $3.5m
- Gliknik Corporate funding round, February 2019: $15m
Gliknik Series C round, June 2021
$11.5m
Gliknik Series B round
$4.9m
Gliknik funding round, January 2011
$3.5m
Gliknik Corporate funding round, February 2019
$15m
Industries
Gliknik Inc. is active in the following industries: